, Tracking Stock Market Picks
Enter Symbol:
Concert Pharmaceuticals Inc. (CNCE) [hlAlert]

up 3.72 %

Concert Pharmaceuticals Inc. (CNCE) rated Outperform by Wells Fargo

Posted on: Monday,  Mar 10, 2014  8:25 AM ET by Wells Fargo

Wells Fargo rated Outperform Concert Pharmaceuticals Inc. (NASDAQ: CNCE) on 03/10/2014, when the stock price was $15.03. Since
then, Concert Pharmaceuticals Inc. has gained 3.73% as of 09/22/2015's recent price of $15.59.
If you would have followed this Wells Fargo's recommendation on CNCE, you would have gained 3.72% of your investment in 561 days.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/10/2014 8:25 AM Buy
as of 10/17/2014
1 Week up  8.13 %
1 Month down  -2.61 %
3 Months up  61.41 %
1 YTD down  -10.64 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy